|
(Health-NewsWire.Net, January 07, 2022 ) The growth in Cell Dissociation Market is attributed to the prevalence of cell based research, the increasing number of pharmaceutical and biotechnology companies
According to the new market research report "Cell Dissociation Market by Product (Enzymatic (Trypsin), Non-enzymatic, Instruments & Accessories), Type (Tissue Dissociation, Cell Detachment), Tissue (Connective, Epithelial), End User (Pharma and Biotech, Research institutes) - Global Forecast to 2026", published by MarketsandMarkets™, is projected to reach USD 561 million by 2026 from USD 282 million in 2021, at a CAGR of 14.7%.
Recent Developments:
- In 2020, Thermo Fisher Scientific Collaborated with Symphogen (Denmark) to Extended its strategic collaboration with Symphogen to advance biopharmaceutical discovery and development. Thermo Fisher Scientific Acquired QIAGEN N.V. (Germany) to expand its Specialty Diagnostics portfolio.
- In 2021, Roche Diagnostics Signed a definitive merger agreement with GenMark Diagnostics to access novel technologies to test for a broad range of pathogens in one patient sample.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=97548003
Enzymatic dissociation products accounted for the larger share of the cell dissociation market in 2020
Based on the product, the market is segmented Enzymatic dissociation products, Non-Enzymatic dissociation products and instruments. In 2020, the Enzymatic dissociation products segment accounted for the larger share of the market. The large share of this segment can be attributed increasing incidence of cell based research.
By tissue, the connective tissue segment accounted for the largest market share in 2020
Based on the tissue, the market is segmented into connective tissues, epethilial tissues and other tissues (skeletal, muscles tissues). The connective tissues segment accounted for the largest market share in 2020. The increasing incidence attributed to cell based research and development in pharmaceutical and biotechnology companies.
By type, the tissue dissociation segment accounted for the largest market share in 2020
Based on type, the cell dissociation market is segmented into tissue dissociation and cell detachment solution. The tissue dissociation solution segment accounted for the largest market share in 2020. Increasing research and development expenditure in pharmaceutical and biotechnology industries drives segment growth.
Pharmaceutical and biotechnology companies are the largest end-users of the cell dissociation market
Based on end-users, the market is segmented into pharmaceutical and biotechnology companies, research and academic institutes and other end users. The pharmaceutical and biotechnology companies s segment accounted for the largest market share in 2020. The increasing insvestments pharmaceutical and biotechnology is the major driving factors for this market.
Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=97548003
The Cell Dissociation Market is segmented into four major regional segments, namely, North America, Europe, Asia Pacific, and the Rest of the World. In 2020, North America accounted for the largest share of the market. The large share of North America can primarily be attributed to the increasing research in pharmaceutical and biotechnology industries and the strong presence of major market players in this region.
The major players in the cell dissociation market are Thermo Fisher Scientific (US), Becton, Dickinson and Company (US), Roche Diagnostics (Switzerland), Cytiva (a part of Danaher Corporation) (US), STEMCELL Technologies (Canada), Miltenyi Biotec (Germany), and PromoCell GmbH (Germany) etc.
Speak to Analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=97548003
MarketsandMarkets™
Mr. Aashish Mehra
1-888-600-6441
raviraj.tak@marketsandmarkets.com
Source: EmailWire.Com 
|
